Efficacy and safety of deferasirox estimated by serum ferritin and labile plasma iron levels in patients with aplastic anemia, myelodysplastic syndrome, or acute myeloid leukemia with transfusional iron overload-Reference-Cited by-同舟云学术

Efficacy and safety of deferasirox estimated by serum ferritin and labile plasma iron levels in patients with aplastic anemia, myelodysplastic syndrome, or acute myeloid leukemia with transfusional iron overload

Published:2015-03-11 Issue:7 Volume:55 Page:1613-1620
ISSN:0041-1132
Container-title:Transfusion
language:en
Short-container-title:Transfusion

Author:

Kim Il-Hwan¹,Moon Joon-Ho²,Lim Sung-Nam¹,Sohn Sang-Kyun²,Kim Hoon-Gu³,Lee Gyeong-Won³,Kim Yang-Soo⁴,Lee Ho-Sup⁴,Kwon Ki-Young⁵,Kim Sung-Hyun⁶,Park Kyung-Tae⁷,Chung Joo-Seop⁸,Lee Won-Sik⁹,Lee Sang-Min⁹,Hyun Myung-Soo¹⁰,Kim Hawk¹¹,Ryoo Hun-Mo¹²,Bae Sung-Hwa¹²,Joo Young-Don¹

Affiliation:

1. Department of Hemato-Oncology; Inje University Haeundae Paik Hospital; Busan

2. Department of Hematology/Oncology; Kyungpook National University Hospital; Daegu

3. Department of Hematology/Oncology; Gyeongsang National University Hospital; Jinju

4. Department of Hematology/Oncology; Kosin University College of Medicine; Busan

5. Department of Hematology/Oncology; Dongsan Medical Center; Daegu

6. Department of Hematology/Oncology; Dong-a University Hospital; Busan

7. Department of Hematology/Oncology; Sungkyunkwan University Samsung Changwon Hospital; Changwon

8. Department of Hematology/Oncology; Pusan National University; Busan

9. Department of Hemato-Oncology; Inje University Busan Paik Hospital; Busan

10. Department of Hematology/Oncology; Yeungnam University Medical Center; Daegu

11. Division of Hematology; Ulsan University Hospital; Ulsan

12. Department of Hematology/Oncology; Daegu Catholic University Medical Center; Daegu Korea

Publisher

Wiley

Subject

Hematology,Immunology,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/trf.13036/fullpdf

Reference28 articles.

1. Iron overload and toxicity: the hidden risk of multiple blood transfusions;Shander;Vox Sang,2009

2. Body iron metabolism and pathophysiology of iron overload;Kohgo;Int J Hematol,2008

3. LPI-labile plasma iron in iron overload;Cabantchik;Best Pract Res Clin Haematol,2005

4. Retrospective study of the association between transfusion frequency and potential complications of iron overload in patients with myelodysplastic syndrome and other acquired hematopoietic disorders;Delea;Curr Med Res Opin,2009

5. Retrospective nationwide survey of Japanese patients with transfusion-dependent MDS and aplastic anemia highlights the negative impact of iron overload on morbidity/mortality;Takatoku;Eur J Haematol,2007

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diagnosis and treatment of transfusion-related iron overload;Journal of the Korean Medical Association;2022-10-10

2. Dose of deferasirox correlates with its effects, which differ between low‐risk myelodysplastic syndrome and aplastic anaemia;Journal of Clinical Pharmacy and Therapeutics;2022-06-24

3. Safety and efficacy of deferasirox in patients with transfusion-dependent thalassemia: A 4-year single-center experience;Pediatric Hematology and Oncology;2021-03-22

4. Iron overload adversely effects bone marrow haematogenesis via SIRT-SOD2-mROS in a process ameliorated by curcumin;Cellular & Molecular Biology Letters;2021-01-13

5. The Effects of Dandelion Polysaccharides on Iron Metabolism by Regulating Hepcidin via JAK/STAT Signaling Pathway;Oxidative Medicine and Cellular Longevity;2021-01-02